/Investor DB

Novalis LifeSciences — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Telesis Biotelesisbio.comin𝕏Jun 2023 · $21M

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.

AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US

Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)inWilliam F. Snider(Director)Andrea L. Jackson(Director)inChristine A. Tsingos(Director)

Co-investorsNorthpond Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.